Exome Asset Management LLC Regenxbio Inc. Transaction History

Exome Asset Management LLC

  • $165 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$5.31 - $10.4 $951,663 - $1.86 Million
-179,221 Reduced 44.22%
226,060 $1.86 Billion
Q1 2025

May 15, 2025
BUY
$5.92 - $8.7 $2.4 Million - $3.53 Million
405,281 New
405,281 $2.9 Billion
Q1 2024

May 15, 2024
BUY
$12.17 - $24.61 $1.03 Million - $2.08 Million
84,470 New
84,470 $1.78 Billion

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $498M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email